The global market for Plasma Protein Therapeutics was valued at US$ 35330 million in the year 2024 and is projected to reach a revised size of US$ 58580 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Plasma Protein Therapeutics Market

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

The plasma protein therapeutics market is driven by the increasing prevalence of rare and chronic diseases such as hemophilia, primary immunodeficiency, and autoimmune disorders, which require life-saving plasma-derived treatments. Advances in plasma fractionation techniques and the growing demand for immunoglobulins, albumin, and clotting factors are further fueling market growth. Additionally, improvements in diagnostic technologies have led to earlier detection and treatment of these conditions, expanding the patient pool for plasma protein therapies. Increasing awareness and access to these treatments in developing regions are also contributing to market expansion.A significant challenge in the plasma protein therapeutics market is the limited availability of plasma due to the complex and time-consuming process of plasma collection and fractionation. This often results in supply shortages, which can affect patient access to essential therapies. The high cost of plasma protein therapies, due to the labor-intensive production process and stringent regulatory requirements, also poses a barrier to treatment affordability. Furthermore, the market faces increasing competition from recombinant therapies, which are being developed as alternatives to plasma-derived products, potentially impacting market share.

Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market. North America is the major region of the global market, which takes about 40% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Plasma Protein Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Protein Therapeutics.

The Plasma Protein Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma Protein Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plasma Protein Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Plasma Protein Therapeutics Market Report

Report Metric	Details
Report Name	Plasma Protein Therapeutics Market
Accounted market size in year	US$ 35330 million
Forecasted market size in 2031	US$ 58580 million
CAGR	7.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Coagulation Factor Immune Globulin Albumin Others
Segment by Application	Hemophilia PID Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma Protein Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Plasma Protein Therapeutics Market growing?

Ans: The Plasma Protein Therapeutics Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Plasma Protein Therapeutics Market size in 2031?

Ans: The Plasma Protein Therapeutics Market size in 2031 will be US$ 58580 million.

What is the market share of major companies in Plasma Protein Therapeutics Market?

Ans: Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market.

What is the Plasma Protein Therapeutics Market share by region?

Ans: North America is the major region of the global market, which takes about 40% market share.

Who are the main players in the Plasma Protein Therapeutics Market report?

Ans: The main players in the Plasma Protein Therapeutics Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Plasma Protein Therapeutics Market report?

Ans: The Applications covered in the Plasma Protein Therapeutics Market report are Hemophilia, PID, Others

What are the Type segmentation covered in the Plasma Protein Therapeutics Market report?

Ans: The Types covered in the Plasma Protein Therapeutics Market report are Coagulation Factor, Immune Globulin, Albumin, Others

1 Plasma Protein Therapeutics Market Overview

1.1 Product Definition

1.2 Plasma Protein Therapeutics by Type

1.2.1 Global Plasma Protein Therapeutics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Coagulation Factor

1.2.3 Immune Globulin

1.2.4 Albumin

1.2.5 Others

1.3 Plasma Protein Therapeutics by Application

1.3.1 Global Plasma Protein Therapeutics Market Value by Application (2024 VS 2031)

1.3.2 Hemophilia

1.3.3 PID

1.3.4 Others

1.4 Global Plasma Protein Therapeutics Market Size Estimates and Forecasts

1.4.1 Global Plasma Protein Therapeutics Revenue 2020-2031

1.4.2 Global Plasma Protein Therapeutics Sales 2020-2031

1.4.3 Global Plasma Protein Therapeutics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Plasma Protein Therapeutics Market Competition by Manufacturers

2.1 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Plasma Protein Therapeutics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Plasma Protein Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Plasma Protein Therapeutics, Product Type & Application

2.7 Global Key Manufacturers of Plasma Protein Therapeutics, Date of Enter into This Industry

2.8 Global Plasma Protein Therapeutics Market Competitive Situation and Trends

2.8.1 Global Plasma Protein Therapeutics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Plasma Protein Therapeutics Players Market Share by Revenue

2.8.3 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Plasma Protein Therapeutics Market Scenario by Region

3.1 Global Plasma Protein Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Plasma Protein Therapeutics Sales by Region: 2020-2031

3.2.1 Global Plasma Protein Therapeutics Sales by Region: 2020-2025

3.2.2 Global Plasma Protein Therapeutics Sales by Region: 2026-2031

3.3 Global Plasma Protein Therapeutics Revenue by Region: 2020-2031

3.3.1 Global Plasma Protein Therapeutics Revenue by Region: 2020-2025

3.3.2 Global Plasma Protein Therapeutics Revenue by Region: 2026-2031

3.4 North America Plasma Protein Therapeutics Market Facts & Figures by Country

3.4.1 North America Plasma Protein Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Plasma Protein Therapeutics Sales by Country (2020-2031)

3.4.3 North America Plasma Protein Therapeutics Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Plasma Protein Therapeutics Market Facts & Figures by Country

3.5.1 Europe Plasma Protein Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Plasma Protein Therapeutics Sales by Country (2020-2031)

3.5.3 Europe Plasma Protein Therapeutics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Plasma Protein Therapeutics Market Facts & Figures by Region

3.6.1 Asia Pacific Plasma Protein Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Plasma Protein Therapeutics Sales by Region (2020-2031)

3.6.3 Asia Pacific Plasma Protein Therapeutics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Plasma Protein Therapeutics Market Facts & Figures by Country

3.7.1 Latin America Plasma Protein Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Plasma Protein Therapeutics Sales by Country (2020-2031)

3.7.3 Latin America Plasma Protein Therapeutics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Plasma Protein Therapeutics Market Facts & Figures by Country

3.8.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Plasma Protein Therapeutics Sales by Type (2020-2031)

4.1.1 Global Plasma Protein Therapeutics Sales by Type (2020-2025)

4.1.2 Global Plasma Protein Therapeutics Sales by Type (2026-2031)

4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2031)

4.2 Global Plasma Protein Therapeutics Revenue by Type (2020-2031)

4.2.1 Global Plasma Protein Therapeutics Revenue by Type (2020-2025)

4.2.2 Global Plasma Protein Therapeutics Revenue by Type (2026-2031)

4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2020-2031)

4.3 Global Plasma Protein Therapeutics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Plasma Protein Therapeutics Sales by Application (2020-2031)

5.1.1 Global Plasma Protein Therapeutics Sales by Application (2020-2025)

5.1.2 Global Plasma Protein Therapeutics Sales by Application (2026-2031)

5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2020-2031)

5.2 Global Plasma Protein Therapeutics Revenue by Application (2020-2031)

5.2.1 Global Plasma Protein Therapeutics Revenue by Application (2020-2025)

5.2.2 Global Plasma Protein Therapeutics Revenue by Application (2026-2031)

5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2020-2031)

5.3 Global Plasma Protein Therapeutics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Company Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Takeda Plasma Protein Therapeutics Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Plasma Protein Therapeutics Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 Grifols

6.3.1 Grifols Company Information

6.3.2 Grifols Description and Business Overview

6.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Grifols Plasma Protein Therapeutics Product Portfolio

6.3.5 Grifols Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 Kedrion

6.5.1 Kedrion Company Information

6.5.2 Kedrion Description and Business Overview

6.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio

6.5.5 Kedrion Recent Developments/Updates

6.6 LFB Group

6.6.1 LFB Group Company Information

6.6.2 LFB Group Description and Business Overview

6.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio

6.6.5 LFB Group Recent Developments/Updates

6.7 Biotest

6.7.1 Biotest Company Information

6.7.2 Biotest Description and Business Overview

6.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Biotest Plasma Protein Therapeutics Product Portfolio

6.7.5 Biotest Recent Developments/Updates

6.8 BPL

6.8.1 BPL Company Information

6.8.2 BPL Description and Business Overview

6.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 BPL Plasma Protein Therapeutics Product Portfolio

6.8.5 BPL Recent Developments/Updates

6.9 RAAS

6.9.1 RAAS Company Information

6.9.2 RAAS Description and Business Overview

6.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 RAAS Plasma Protein Therapeutics Product Portfolio

6.9.5 RAAS Recent Developments/Updates

6.10 CBPO

6.10.1 CBPO Company Information

6.10.2 CBPO Description and Business Overview

6.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 CBPO Plasma Protein Therapeutics Product Portfolio

6.10.5 CBPO Recent Developments/Updates

6.11 Hualan Bio

6.11.1 Hualan Bio Company Information

6.11.2 Hualan Bio Description and Business Overview

6.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio

6.11.5 Hualan Bio Recent Developments/Updates

6.12 Tiantan Bio

6.12.1 Tiantan Bio Company Information

6.12.2 Tiantan Bio Description and Business Overview

6.12.3 Tiantan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Tiantan Bio Plasma Protein Therapeutics Product Portfolio

6.12.5 Tiantan Bio Recent Developments/Updates

6.13 Shuanglin Bio

6.13.1 Shuanglin Bio Company Information

6.13.2 Shuanglin Bio Description and Business Overview

6.13.3 Shuanglin Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shuanglin Bio Plasma Protein Therapeutics Product Portfolio

6.13.5 Shuanglin Bio Recent Developments/Updates

6.14 Boya Bio

6.14.1 Boya Bio Company Information

6.14.2 Boya Bio Description and Business Overview

6.14.3 Boya Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Boya Bio Plasma Protein Therapeutics Product Portfolio

6.14.5 Boya Bio Recent Developments/Updates

6.15 Yuanda Shuyang

6.15.1 Yuanda Shuyang Company Information

6.15.2 Yuanda Shuyang Description and Business Overview

6.15.3 Yuanda Shuyang Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Yuanda Shuyang Plasma Protein Therapeutics Product Portfolio

6.15.5 Yuanda Shuyang Recent Developments/Updates

6.16 Weiguang Bio

6.16.1 Weiguang Bio Company Information

6.16.2 Weiguang Bio Description and Business Overview

6.16.3 Weiguang Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Weiguang Bio Plasma Protein Therapeutics Product Portfolio

6.16.5 Weiguang Bio Recent Developments/Updates

6.17 Nanyue Bio

6.17.1 Nanyue Bio Company Information

6.17.2 Nanyue Bio Description and Business Overview

6.17.3 Nanyue Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Nanyue Bio Plasma Protein Therapeutics Product Portfolio

6.17.5 Nanyue Bio Recent Developments/Updates

6.18 KM Biologics

6.18.1 KM Biologics Company Information

6.18.2 KM Biologics Description and Business Overview

6.18.3 KM Biologics Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.18.4 KM Biologics Plasma Protein Therapeutics Product Portfolio

6.18.5 KM Biologics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Plasma Protein Therapeutics Industry Chain Analysis

7.2 Plasma Protein Therapeutics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Plasma Protein Therapeutics Production Mode & Process Analysis

7.4 Plasma Protein Therapeutics Sales and Marketing

7.4.1 Plasma Protein Therapeutics Sales Channels

7.4.2 Plasma Protein Therapeutics Distributors

7.5 Plasma Protein Therapeutics Customer Analysis

8 Plasma Protein Therapeutics Market Dynamics

8.1 Plasma Protein Therapeutics Industry Trends

8.2 Plasma Protein Therapeutics Market Drivers

8.3 Plasma Protein Therapeutics Market Challenges

8.4 Plasma Protein Therapeutics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Plasma Protein Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Plasma Protein Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Plasma Protein Therapeutics Market Competitive Situation by Manufacturers in 2024

Table 4. Global Plasma Protein Therapeutics Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Plasma Protein Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Plasma Protein Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Plasma Protein Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Plasma Protein Therapeutics, Product Type & Application

Table 12. Global Key Manufacturers of Plasma Protein Therapeutics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Plasma Protein Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Plasma Protein Therapeutics Sales by Region (2020-2025) & (K Units)

Table 18. Global Plasma Protein Therapeutics Sales Market Share by Region (2020-2025)

Table 19. Global Plasma Protein Therapeutics Sales by Region (2026-2031) & (K Units)

Table 20. Global Plasma Protein Therapeutics Sales Market Share by Region (2026-2031)

Table 21. Global Plasma Protein Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Plasma Protein Therapeutics Revenue Market Share by Region (2020-2025)

Table 23. Global Plasma Protein Therapeutics Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Plasma Protein Therapeutics Revenue Market Share by Region (2026-2031)

Table 25. North America Plasma Protein Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)

Table 27. North America Plasma Protein Therapeutics Sales by Country (2026-2031) & (K Units)

Table 28. North America Plasma Protein Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Plasma Protein Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Plasma Protein Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)

Table 32. Europe Plasma Protein Therapeutics Sales by Country (2026-2031) & (K Units)

Table 33. Europe Plasma Protein Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Plasma Protein Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Plasma Protein Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Plasma Protein Therapeutics Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Plasma Protein Therapeutics Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Plasma Protein Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Plasma Protein Therapeutics Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Plasma Protein Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Plasma Protein Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Plasma Protein Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Plasma Protein Therapeutics Sales (K Units) by Type (2020-2025)

Table 51. Global Plasma Protein Therapeutics Sales (K Units) by Type (2026-2031)

Table 52. Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)

Table 53. Global Plasma Protein Therapeutics Sales Market Share by Type (2026-2031)

Table 54. Global Plasma Protein Therapeutics Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Plasma Protein Therapeutics Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Plasma Protein Therapeutics Revenue Market Share by Type (2020-2025)

Table 57. Global Plasma Protein Therapeutics Revenue Market Share by Type (2026-2031)

Table 58. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2020-2025)

Table 59. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2026-2031)

Table 60. Global Plasma Protein Therapeutics Sales (K Units) by Application (2020-2025)

Table 61. Global Plasma Protein Therapeutics Sales (K Units) by Application (2026-2031)

Table 62. Global Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)

Table 63. Global Plasma Protein Therapeutics Sales Market Share by Application (2026-2031)

Table 64. Global Plasma Protein Therapeutics Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Plasma Protein Therapeutics Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Plasma Protein Therapeutics Revenue Market Share by Application (2020-2025)

Table 67. Global Plasma Protein Therapeutics Revenue Market Share by Application (2026-2031)

Table 68. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2020-2025)

Table 69. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2026-2031)

Table 70. Takeda Company Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Takeda Plasma Protein Therapeutics Product

Table 74. Takeda Recent Developments/Updates

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. CSL Plasma Protein Therapeutics Product

Table 79. CSL Recent Developments/Updates

Table 80. Grifols Company Information

Table 81. Grifols Description and Business Overview

Table 82. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Grifols Plasma Protein Therapeutics Product

Table 84. Grifols Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Octapharma Plasma Protein Therapeutics Product

Table 89. Octapharma Recent Developments/Updates

Table 90. Kedrion Company Information

Table 91. Kedrion Description and Business Overview

Table 92. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Kedrion Plasma Protein Therapeutics Product

Table 94. Kedrion Recent Developments/Updates

Table 95. LFB Group Company Information

Table 96. LFB Group Description and Business Overview

Table 97. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. LFB Group Plasma Protein Therapeutics Product

Table 99. LFB Group Recent Developments/Updates

Table 100. Biotest Company Information

Table 101. Biotest Description and Business Overview

Table 102. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Biotest Plasma Protein Therapeutics Product

Table 104. Biotest Recent Developments/Updates

Table 105. BPL Company Information

Table 106. BPL Description and Business Overview

Table 107. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. BPL Plasma Protein Therapeutics Product

Table 109. BPL Recent Developments/Updates

Table 110. RAAS Company Information

Table 111. RAAS Description and Business Overview

Table 112. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. RAAS Plasma Protein Therapeutics Product

Table 114. RAAS Recent Developments/Updates

Table 115. CBPO Company Information

Table 116. CBPO Description and Business Overview

Table 117. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. CBPO Plasma Protein Therapeutics Product

Table 119. CBPO Recent Developments/Updates

Table 120. Hualan Bio Company Information

Table 121. Hualan Bio Description and Business Overview

Table 122. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Hualan Bio Plasma Protein Therapeutics Product

Table 124. Hualan Bio Recent Developments/Updates

Table 125. Tiantan Bio Company Information

Table 126. Tiantan Bio Description and Business Overview

Table 127. Tiantan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Tiantan Bio Plasma Protein Therapeutics Product

Table 129. Tiantan Bio Recent Developments/Updates

Table 130. Shuanglin Bio Company Information

Table 131. Shuanglin Bio Description and Business Overview

Table 132. Shuanglin Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Shuanglin Bio Plasma Protein Therapeutics Product

Table 134. Shuanglin Bio Recent Developments/Updates

Table 135. Boya Bio Company Information

Table 136. Boya Bio Description and Business Overview

Table 137. Boya Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Boya Bio Plasma Protein Therapeutics Product

Table 139. Boya Bio Recent Developments/Updates

Table 140. Yuanda Shuyang Company Information

Table 141. Yuanda Shuyang Description and Business Overview

Table 142. Yuanda Shuyang Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Yuanda Shuyang Plasma Protein Therapeutics Product

Table 144. Yuanda Shuyang Recent Developments/Updates

Table 145. Weiguang Bio Company Information

Table 146. Weiguang Bio Description and Business Overview

Table 147. Weiguang Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Weiguang Bio Plasma Protein Therapeutics Product

Table 149. Weiguang Bio Recent Developments/Updates

Table 150. Nanyue Bio Company Information

Table 151. Nanyue Bio Description and Business Overview

Table 152. Nanyue Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Nanyue Bio Plasma Protein Therapeutics Product

Table 154. Nanyue Bio Recent Developments/Updates

Table 155. KM Biologics Company Information

Table 156. KM Biologics Description and Business Overview

Table 157. KM Biologics Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. KM Biologics Plasma Protein Therapeutics Product

Table 159. KM Biologics Recent Developments/Updates

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Plasma Protein Therapeutics Distributors List

Table 163. Plasma Protein Therapeutics Customers List

Table 164. Plasma Protein Therapeutics Market Trends

Table 165. Plasma Protein Therapeutics Market Drivers

Table 166. Plasma Protein Therapeutics Market Challenges

Table 167. Plasma Protein Therapeutics Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

Table 171. Authors List of This Report

List of Figures

Figure 1. Product Picture of Plasma Protein Therapeutics

Figure 2. Global Plasma Protein Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Plasma Protein Therapeutics Market Share by Type: 2024 & 2031

Figure 4. Coagulation Factor Product Picture

Figure 5. Immune Globulin Product Picture

Figure 6. Albumin Product Picture

Figure 7. Others Product Picture

Figure 8. Global Plasma Protein Therapeutics Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Plasma Protein Therapeutics Market Share by Application: 2024 & 2031

Figure 10. Hemophilia

Figure 11. PID

Figure 12. Others

Figure 13. Global Plasma Protein Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Plasma Protein Therapeutics Market Size (2020-2031) & (US$ Million)

Figure 15. Global Plasma Protein Therapeutics Sales (2020-2031) & (K Units)

Figure 16. Global Plasma Protein Therapeutics Average Price (USD/Unit) & (2020-2031)

Figure 17. Plasma Protein Therapeutics Report Years Considered

Figure 18. Plasma Protein Therapeutics Sales Share by Manufacturers in 2024

Figure 19. Global Plasma Protein Therapeutics Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Plasma Protein Therapeutics Players: Market Share by Revenue in Plasma Protein Therapeutics in 2024

Figure 21. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Plasma Protein Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Plasma Protein Therapeutics Sales Market Share by Country (2020-2031)

Figure 24. North America Plasma Protein Therapeutics Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Plasma Protein Therapeutics Sales Market Share by Country (2020-2031)

Figure 28. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2020-2031)

Figure 29. Germany Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Region (2020-2031)

Figure 36. China Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Plasma Protein Therapeutics Sales Market Share by Country (2020-2031)

Figure 47. Latin America Plasma Protein Therapeutics Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Plasma Protein Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Plasma Protein Therapeutics by Type (2020-2031)

Figure 57. Global Revenue Market Share of Plasma Protein Therapeutics by Type (2020-2031)

Figure 58. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Plasma Protein Therapeutics by Application (2020-2031)

Figure 60. Global Revenue Market Share of Plasma Protein Therapeutics by Application (2020-2031)

Figure 61. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2020-2031)

Figure 62. Plasma Protein Therapeutics Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions